Td Asset Management Inc Biotechnology

Td Asset Management Inc

$102 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
JANX Janux Therapeutics, Inc.	$1.03B	$1.77 Million 0.0% of portfolio	65,636	Q1 2025 Reduced 16.74%
BCYC Bicycle Therapeutics PLC	$252M	$1.64 Million 0.0% of portfolio	193,092	Q1 2025 Reduced 10.61%
CLDX Celldex Therapeutics, Inc.	$913M	$1.43 Million 0.0% of portfolio	78,878	Q1 2025 Reduced 45.18%
WVE Wave Life Sciences Ltd.	$606M	$1.25 Million 0.0% of portfolio	154,408	Q1 2025 Reduced 51.17%
PHVS Pharvaris N.V.	$542M	$1.23 Million 0.0% of portfolio	78,122	Q1 2025 Added 41.48%
IMTX Immatics N.V.	$441M	$1.09 Million 0.0% of portfolio	241,246	Q1 2025 Reduced 5.13%
RCKT Rocket Pharmaceuticals, Inc.	$210M	$1.09 Million 0.0% of portfolio	162,710	Q1 2025 Reduced 8.82%
XNCR Xencor Inc	$544M	$1.08 Million 0.0% of portfolio	101,722	Q1 2025 Reduced 9.76%
AXSM Axsome Therapeutics, Inc.	$4.74B	$1.05 Million 0.0% of portfolio	8,984	Q1 2025 New
BNTX Bio N Tech Se	$26.7B	$1.04 Million 0.0% of portfolio	11,452	Q1 2025 Reduced 73.96%
HRTX Heron Therapeutics, Inc.	$247M	$868,000 0.0% of portfolio	394,600	Q1 2025 New
ORIC Oric Pharmaceuticals, Inc.	$388M	$852,000 0.0% of portfolio	152,700	Q1 2025 Added 3.32%
GLUE Monte Rosa Therapeutics, Inc.	$216M	$798,000 0.0% of portfolio	172,078	Q1 2025 Reduced 21.82%
ALLO Allogene Therapeutics, Inc.	$186M	$796,000 0.0% of portfolio	545,388	Q4 2024 Reduced 19.46%
PRTA Prothena Corp Public LTD CO	$237M	$776,000 0.0% of portfolio	62,694	Q1 2025 Reduced 3.09%
EWTX Edgewise Therapeutics, Inc.	$936M	$730,000 0.0% of portfolio	33,200	Q1 2025 New
ARWR Arrowhead Pharmaceuticals, Inc.	$1.74B	$721,000 0.0% of portfolio	56,606	Q1 2025 Reduced 11.25%
ARVN Arvinas, Inc.	$368M	$715,000 0.0% of portfolio	101,926	Q1 2025 Reduced 16.69%
URGN Uro Gen Pharma Ltd.	$131M	$590,000 0.0% of portfolio	53,400	Q4 2024 New
IDYA Ideaya Biosciences, Inc.	$1.01B	$573,000 0.0% of portfolio	35,036	Q1 2025 Reduced 46.34%
LYEL Lyell Immunopharma, Inc.	$2.84B	$542,000 0.0% of portfolio	1,004,642	Q2 2024 Added 4.23%
SANA Sana Biotechnology, Inc.	$485M	$519,000 0.0% of portfolio	309,034	Q1 2025 Reduced 23.57%
NRIX Nurix Therapeutics, Inc.	$589M	$503,000 0.0% of portfolio	42,420	Q1 2025 Added 8.12%
IOVA Iovance Biotherapeutics, Inc.	$284M	$465,000 0.0% of portfolio	139,878	Q1 2025 Reduced 55.03%
VRDN Viridian Therapeutics, Inc.\De	$579M	$439,000 0.0% of portfolio	32,600	Q1 2025 Reduced 36.33%
TRDA Entrada Therapeutics, Inc.	$255M	$432,000 0.0% of portfolio	47,788	Q3 2024 Reduced 32.98%
RLAY Relay Therapeutics, Inc.	$390M	$409,000 0.0% of portfolio	156,456	Q4 2024 Reduced 16.18%
AURA Aura Biosciences, Inc.	$179M	$404,000 0.0% of portfolio	69,030	Q4 2024 Added 14.99%
ELYM Eliem Therapeutics, Inc.	$109M	$367,000 0.0% of portfolio	89,400	Q3 2024 New
ERAS Erasca, Inc.	$192M	$350,000 0.0% of portfolio	256,032	Q1 2025 Added 6.35%
VYGR Voyager Therapeutics, Inc.	$138M	$257,000 0.0% of portfolio	76,330	Q1 2025 Reduced 33.59%
BDTX Black Diamond Therapeutics, Inc.	$89.4M	$256,000 0.0% of portfolio	165,678	Q4 2024 Reduced 24.58%
DYN Dyne Therapeutics, Inc.	$737M	$226,000 0.0% of portfolio	21,656	Q1 2025 Reduced 69.93%
ALEC Alector, Inc.	$116M	$137,000 0.0% of portfolio	111,738	Q4 2023 Reduced 6.21%
GBIO Generation Bio Co.	$22.4M	$136,000 0.0% of portfolio	340,686	Q4 2023 Reduced 16.21%
CABA Cabaletta Bio, Inc.	$63.3M	$123,000 0.0% of portfolio	88,600	Q3 2024 Reduced 33.9%
PRLD Prelude Therapeutics Inc	$36.4M	$123,000 0.0% of portfolio	160,652	Q3 2023 Added 100.0%
IMRX Immuneering Corp	$49.4M	$108,000 0.0% of portfolio	71,066	Q1 2025 Reduced 52.9%
ANNX Annexon, Inc.	$130M	$90,000 0.0% of portfolio	46,848	Q1 2025 Reduced 64.95%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.